Japan Lists Eight Infectious Diseases For Focused Vaccine Development
Funding For Vaccine R&D Projects Ongoing
The list including eight types of diseases such as flu and coronavirus infection, smallpox will be sent to SCARDA to determine which domestic vaccine development projects by pharmaceutical firms are to be funded. Some participants at the Ministry of Health, Labour and Welfare’s discussion insisted on continuous monitoring.
You may also be interested in...
Japan's SCARDA is building networks with academia and industry to support new vaccine development, while offering support through funding and knowledge. But is that enough to overcome the shortcomings highlighted by the pandemic?
Japan has kick-started discussions on incentives for R&D and continued marketing of antibiotics as part of broader measures to counter resistance issues and industry reluctance to develop new drugs. The country plans to open applications for a pilot project in the summer after initial discussions on specific targets.
A roundup of key regulatory and policy developments in the Asia-Pacific in the first half of the year reveals broad developments across the region's diverse markets, although there seemed to be a common thread - a renewed focus on infectious diseases amid the lingering impact of the pandemic and the emergence of new threats.